Then the expression of SDCBP2-AS1 was detected during osteogenic stimulation (0,7, 14 days) and the levels of SDCBP2-AS1 also showed an increasing trend in hBMSCs (Fig. 3 B).
← all excerpts
LncRNA SDCBP2-AS1 is a putative biomarker for postmenopausal osteoporosis and promotes osteogenic differentiation of BMSCs by regulating miR-361-3p.
1
—
—